• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VOCO GMBH FUTURABOND M+

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VOCO GMBH FUTURABOND M+ Back to Search Results
Catalog Number REF 1515
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Rash (2033)
Event Date 11/01/2021
Event Type  Injury  
Event Description
One patient received treatment under general anesthesia approximately 6 weeks ago.During this session, two small composite fillings (11 and 38) were placed and five ceramic inlays were fabricated and cemented in place.According to the patient, he has not been well since this treatment.He had a skin rash all over his body.The patient is currently being treated by a dermatologist.The products used had been given to the treating physician for testing.With futurabond m+, there had been an anomaly.It is not known what this abnormality consisted of.The following products were used for the treatment: tetric evo ceran - ivoclar vivadent, tetric evo flow - ivoclar vivadent, estelite universal flow - tokuyama dental, cerec inlays, futurabond m+ - voco gmbh.
 
Manufacturer Narrative
Futurabond m+ contains organic acids, (di-)methacrylates, amines (dabe) and bht.Intolerances/allergies to these ingredients cannot be excluded.The instructions for use contain corresponding warnings.In general, futurabond m+ has only a very low allergenic potential when used correctly.The adhesive is used in very small quantities and sealed by the composite filling after polymerization.In our opinion, it is unlikely that the incident was caused by futurabond m+.We are not aware of any similar cases related to futurabond m+.According to our information, the dentist used estelite universal flow from tokuyama dental for bonding the ceramic inlays.This indication is not covered by the manufacturer for this product.The purely light-curing product will possibly not polymerize or polymerize insufficiently under a ceramic restoration.This may result in prolonged and undesirable exposure of the patient to free methacrylates and may leading to the reported persistent reactions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FUTURABOND M+
Type of Device
FUTURABOND M+
Manufacturer (Section D)
VOCO GMBH
anton-flettner-strasse 1-3
cuxhaven, niedersachsen 27472
GM  27472
Manufacturer (Section G)
VOCO GMBH
anton-flettner-strasse 1-3
cuxhaven, niedersachsen 27472
GM   27472
Manufacturer Contact
michael cyll
anton-flettner-strasse 1-3
cuxhaven, niedersachsen 27472
GM   27472
MDR Report Key13024172
MDR Text Key288112821
Report Number8010908-2021-00009
Device Sequence Number1
Product Code KLE
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K141610
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Dentist
Type of Report Initial
Report Date 12/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/17/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberREF 1515
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age41 YR
Patient SexMale
-
-